TY - JOUR
T1 - TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis
AU - Inokuchi-Shimizu, Sayaka
AU - Park, Eek Joong
AU - Roh, Yoon Seok
AU - Yang, Ling
AU - Zhang, Bi
AU - Song, Jingyi
AU - Liang, Shuang
AU - Pimienta, Michael
AU - Taniguchi, Koji
AU - Wu, Xuefeng
AU - Asahina, Kinji
AU - Lagakos, William
AU - Mackey, Mason R.
AU - Akira, Shizuo
AU - Ellisman, Mark H.
AU - Sears, Dorothy D.
AU - Olefsky, Jerrold M.
AU - Karin, Michael
AU - Brenner, David A.
AU - Seki, Ekihiro
PY - 2014/8/1
Y1 - 2014/8/1
N2 - The MAP kinase kinase kinase TGFβ-activated kinase 1 (TAK1) is activated by TLRs, IL-1, TNF, and TGFβ and in turn activates IKK-NF-κB and JNK, which regulate cell survival, growth, tumorigenesis, and metabolism. TAK1 signaling also upregulates AMPK activity and autophagy. Here, we investigated TAK1-dependent regulation of autophagy, lipid metabolism, and tumorigenesis in the liver. Fasted mice with hepatocyte-specific deletion of Tak1 exhibited severe hepatosteatosis with increased mTORC1 activity and suppression of autophagy compared with their WT counterparts. TAK1-deficient hepatocytes exhibited suppressed AMPK activity and autophagy in response to starvation or metformin treatment; however, ectopic activation of AMPK restored autophagy in these cells. Peroxisome proliferator-activated receptor α (PPARα) target genes and β-oxidation, which regulate hepatic lipid degradation, were also suppressed in hepatocytes lacking TAK1. Due to suppression of autophagy and β-oxidation, a high-fat diet challenge aggravated steatohepatitis in mice with hepatocyte-specific deletion of Tak1. Notably, inhibition of mTORC1 restored autophagy and PPARα target gene expression in TAK1-deficient livers, indicating that TAK1 acts upstream of mTORC1. mTORC1 inhibition also suppressed spontaneous liver fibrosis and hepatocarcinogenesis in animals with hepatocyte-specific deletion of Tak1. These data indicate that TAK1 regulates hepatic lipid metabolism and tumorigenesis via the AMPK/mTORC1 axis, affecting both autophagy and PPARα activity.
AB - The MAP kinase kinase kinase TGFβ-activated kinase 1 (TAK1) is activated by TLRs, IL-1, TNF, and TGFβ and in turn activates IKK-NF-κB and JNK, which regulate cell survival, growth, tumorigenesis, and metabolism. TAK1 signaling also upregulates AMPK activity and autophagy. Here, we investigated TAK1-dependent regulation of autophagy, lipid metabolism, and tumorigenesis in the liver. Fasted mice with hepatocyte-specific deletion of Tak1 exhibited severe hepatosteatosis with increased mTORC1 activity and suppression of autophagy compared with their WT counterparts. TAK1-deficient hepatocytes exhibited suppressed AMPK activity and autophagy in response to starvation or metformin treatment; however, ectopic activation of AMPK restored autophagy in these cells. Peroxisome proliferator-activated receptor α (PPARα) target genes and β-oxidation, which regulate hepatic lipid degradation, were also suppressed in hepatocytes lacking TAK1. Due to suppression of autophagy and β-oxidation, a high-fat diet challenge aggravated steatohepatitis in mice with hepatocyte-specific deletion of Tak1. Notably, inhibition of mTORC1 restored autophagy and PPARα target gene expression in TAK1-deficient livers, indicating that TAK1 acts upstream of mTORC1. mTORC1 inhibition also suppressed spontaneous liver fibrosis and hepatocarcinogenesis in animals with hepatocyte-specific deletion of Tak1. These data indicate that TAK1 regulates hepatic lipid metabolism and tumorigenesis via the AMPK/mTORC1 axis, affecting both autophagy and PPARα activity.
UR - http://www.scopus.com/inward/record.url?scp=84905472344&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84905472344&partnerID=8YFLogxK
U2 - 10.1172/JCI74068
DO - 10.1172/JCI74068
M3 - Article
C2 - 24983318
AN - SCOPUS:84905472344
SN - 0021-9738
VL - 124
SP - 3566
EP - 3578
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 8
ER -